To: FDA Drug Info and Ms. Glendolynn Johnson, Peripheral and Central Nervous System Drugs Advisory Committee

Thousands of Multiple Sclerosis patients are getting worse each day; They need another Option, an...

Victory! The creator of this petition declared the campaign a success. You can still sign the petition to show support.

We seek an FDA reversal on their December 30, 2013 decision to NOT approve Sanofi’s Lemtrada, a Multiple Sclerosis Treatment. Patients needs this Medication-option Approved

Why is this important?

Thousands of Multiple Sclerosis patients are getting worse each day, when currently used medications are not working for them or their body refuses to accept the medication.

Another Option is needed and this Option Should be Lemtrada

The FDA on December 30, 2013 Denies the use of Lemtrada for MS Patients. THIS was A sad day for people with more active Multiple Sclerosis.

Lemtrada has been approved worldwide, but not good enough for us it seems, in the USA.

We are more than 400,000 strong (living with MS) in the USA
WE NEED YOUR VOTE to give another OPTION to those that Can benefit from this medication; hoping to keep them from severe disability.

YES, WE NEED YOUR VOTE.
Also we need you to write directly. WE NEED YOU TO send emails. –
We need this request to go Viral --

• Let us FLOOD the OFFICE of this FDA committee with emails, WITH the information shown above.
• Please copy and paste what is tyoed and attach your name to that email and then send to: [email protected] where the communications are reviewed and forwarded to appropriate individuals for response.

In contacting the office of Ms. Glendolynn Johnson, who staffs the Peripheral and Central Nervous System Drugs Advisory Committee, I was advised that the Moveon.org petition, and all communication voicing consumer or prospective patient views, should go to [email protected] where the communications are reviewed and forwarded to appropriate individuals for response.